IL1B and sleep disorder: Previous studies have shown that increased production of pro-inflammatory cytokines, such as IL-1β and IFN-α, and their enhanced secretion (39) lead to changes in responsive neuroendocrine and central neurotransmitters in response to stress, resulting in various depressive symptoms such as weight loss, general malaise, and sleep disorders (50).